Could retraining movement ease the pain of polymyalgia rheumatica?
NCT ID NCT07749547
First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time
Summary
This trial tests whether a personalized rehabilitation program called Movement Pattern Training can help people with polymyalgia rheumatica (PMR) reduce pain and improve their ability to do daily activities. The program includes motivational interviewing, activity-specific training, and a home exercise routine. The study will assess if a larger trial is feasible and gather preliminary data on its effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Movement Pattern Training (MoveTrain), a personalized rehabilitation program
- What this could lead to
- If this approach works, it could offer a non-drug way to reduce pain and improve daily function for people with polymyalgia rheumatica.
- What could go wrong
- This is a small feasibility study, so results may not be conclusive. The training requires commitment, and its benefits over standard care are not yet proven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYMYALGIA RHEUMATICA (PMR) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- DNA clues could forecast steroid relapse in PMR
- New drug combo aims to cut steroid use in painful rheumatic condition
- Blood test may detect hidden giant cell arteritis in PMR patients
- New scan could spare elderly from unnecessary steroid side effects
- Steroid withdrawal relief: new study tests hydrocortisone for exhausted patients
- New blood test could end Trial-and-Error for arthritis drugs